Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Chad Messer's Stock Ratings
Lake Street Analyst
Chad Messer is an analyst at Lake Street. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/16/2025
Overall Average Return
-26.6%
Smart Score
Overall Average Return Percentile
8th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 04/02/2025 | LTRN | Buy Now | Lantern Pharma | $3.86 | 547.67% | Chad Messer34% | → $25 | Initiates | → Buy | Get Alert |
| 04/02/2025 | IMNM | Buy Now | Immunome | $7.95 | 189.31% | Chad Messer34% | → $23 | Initiates | → Buy | Get Alert |
| 04/02/2025 | OSTX | Buy Now | OS Therapies | $1.64 | 1058.54% | Chad Messer34% | → $19 | Initiates | → Buy | Get Alert |
| 08/03/2021 | ESPR | Buy Now | Esperion Therapeutics | $0.80 | 14185.71% | Chad Messer34% | $134 → $114 | Maintains | Strong Buy | Get Alert |
| 07/27/2021 | CELC | Buy Now | Celcuity | $10.61 | 371.25% | Chad Messer34% | → $50 | Initiates | → Buy | Get Alert |
| 07/19/2021 | CYTK | Buy Now | Cytokinetics | $30.97 | 54.99% | Chad Messer34% | $33 → $48 | Maintains | Buy | Get Alert |
| 06/28/2021 | EXEL | Buy Now | Exelixis | $45.04 | -33.39% | Chad Messer34% | $33 → $30 | Maintains | Buy | Get Alert |
| 06/17/2021 | PHAS | Buy Now | PhaseBio Pharmaceuticals | — | — | Chad Messer34% | $16 → $15 | Maintains | Buy | Get Alert |
| 06/17/2021 | RNA | Buy Now | Avidity Biosciences | $30.45 | 64.2% | Chad Messer34% | → $50 | Initiates | → Buy | Get Alert |
| 05/14/2021 | CRMD | Buy Now | Cormedix | $12.02 | 141.21% | Chad Messer34% | $31 → $29 | Maintains | Buy | Get Alert |
| 04/05/2021 | MREO | Buy Now | Mereo BioPharma Group | $2.29 | 336.68% | Chad Messer34% | → $10 | Initiates | → Buy | Get Alert |
| 03/23/2021 | IONS | Buy Now | Ionis Pharmaceuticals | $33.33 | 158.03% | Chad Messer34% | $95 → $86 | Maintains | Buy | Get Alert |
| 03/16/2021 | PHAS | Buy Now | PhaseBio Pharmaceuticals | — | — | Chad Messer34% | $18 → $19 | Maintains | Buy | Get Alert |
| 03/15/2021 | IMAB | Buy Now | I-MAB | $0.93 | 7964.52% | Chad Messer34% | → $75 | Initiates | → Buy | Get Alert |
| 03/09/2021 | GMDA | Buy Now | Gamida Cell | — | — | Chad Messer34% | $17 → $14 | Maintains | Buy | Get Alert |
| 02/25/2021 | GTHX | Buy Now | G1 Therapeutics | — | — | Chad Messer34% | $74 → $68 | Maintains | Buy | Get Alert |
| 02/24/2021 | ESPR | Buy Now | Esperion Therapeutics | $0.80 | 16691.98% | Chad Messer34% | $150 → $134 | Maintains | Strong Buy | Get Alert |
| 02/17/2021 | CRMD | Buy Now | Cormedix | $12.02 | 157.85% | Chad Messer34% | → $31 | Initiates | → Buy | Get Alert |
| 02/11/2021 | GNCA | Buy Now | Genocea Biosciences | — | — | Chad Messer34% | $7 → $6 | Maintains | Buy | Get Alert |
| 01/08/2021 | NRIX | Buy Now | Nurix Therapeutics | $9.60 | 358.33% | Chad Messer34% | $35 → $44 | Maintains | Buy | Get Alert |
| 01/08/2021 | SRPT | Buy Now | Sarepta Therapeutics | $36.00 | 361.11% | Chad Messer34% | $182 → $166 | Maintains | Buy | Get Alert |
| 09/01/2020 | IONS | Buy Now | Ionis Pharmaceuticals | $33.33 | 173.03% | Chad Messer34% | $89 → $91 | Maintains | Buy | Get Alert |
| 08/18/2020 | NRIX | Buy Now | Nurix Therapeutics | $9.60 | 264.58% | Chad Messer34% | → $35 | Initiates | → Buy | Get Alert |
| 07/30/2020 | GNCA | Buy Now | Genocea Biosciences | — | — | Chad Messer34% | $10 → $7 | Maintains | Buy | Get Alert |
| 07/16/2020 | CYTK | Buy Now | Cytokinetics | $30.97 | 45.3% | Chad Messer34% | $34 → $45 | Maintains | Buy | Get Alert |
| 06/30/2020 | SGEN | Buy Now | Seagen | — | — | Chad Messer34% | $163 → $188 | Maintains | Buy | Get Alert |
| 05/21/2020 | GMDA | Buy Now | Gamida Cell | — | — | Chad Messer34% | $19 → $17 | Maintains | Buy | Get Alert |
| 05/08/2020 | ATHX | Buy Now | Athersys | — | — | Chad Messer34% | $6 → $5 | Maintains | Buy | Get Alert |
| 05/07/2020 | AGLE | Buy Now | Aeglea BioTherapeutics | — | — | Chad Messer34% | $14 → $11 | Maintains | Buy | Get Alert |
| 05/05/2020 | AKBA | Buy Now | Akebia Therapeutics | $2.57 | 600.42% | Chad Messer34% | $15 → $18 | Maintains | Buy | Get Alert |
| 05/01/2020 | SGEN | Buy Now | Seagen | — | — | Chad Messer34% | $157 → $163 | Maintains | Buy | Get Alert |
| 04/20/2020 | EXEL | Buy Now | Exelixis | $45.04 | -26.73% | Chad Messer34% | $28 → $33 | Maintains | Buy | Get Alert |
| 04/20/2020 | SGEN | Buy Now | Seagen | — | — | Chad Messer34% | $144 → $157 | Maintains | Buy | Get Alert |
| 02/24/2020 | ESPR | Buy Now | Esperion Therapeutics | $0.80 | 19699.5% | Chad Messer34% | $144 → $158 | Maintains | Strong Buy | Get Alert |
| 09/18/2018 | AKCA | Buy Now | Akcea Therapeutics | — | — | Chad Messer34% | → $45 | Initiates | → Buy | Get Alert |
| 01/05/2018 | JUNO | Buy Now | Juno Therapeutics | — | — | Chad Messer34% | → $65 | Initiates | → Buy | Get Alert |
| 12/14/2017 | ARQL | Buy Now | Arqule | — | — | Chad Messer34% | — | Upgrade | Hold → Buy | Get Alert |
| 06/12/2017 | GTHX | Buy Now | G1 Therapeutics | — | — | Chad Messer34% | → $34 | Initiates | → Buy | Get Alert |
| 03/31/2017 | EXEL | Buy Now | Exelixis | $45.04 | -37.83% | Chad Messer34% | → $28 | Initiates | → Buy | Get Alert |
| 02/23/2017 | ARGS | Buy Now | Argos Therapeutics | — | — | Chad Messer34% | — | Downgrade | Buy → Hold | Get Alert |
| 02/07/2017 | ATHX | Buy Now | Athersys | — | — | Chad Messer34% | → $7 | Initiates | → Buy | Get Alert |
| 02/12/2014 | SGEN | Buy Now | Seagen | — | — | Chad Messer34% | — | Upgrade | Hold → Buy | Get Alert |
| 02/13/2013 | SGEN | Buy Now | Seagen | — | — | Chad Messer34% | — | Downgrade | Buy → Hold | Get Alert |
